Bayer Aktien Stock Price, News & Analysis

Bayer (OTC:BAYRY) has announced the expansion of its "Take Care, Now" campaign in partnership with country star Luke Bryan and Feeding America®, marking their 10-year collaboration anniversary. The campaign addresses food insecurity and "hidden hunger" in rural America through multiple initiatives.

The campaign features a social media initiative #HeresToTheFarmer, where Bayer will donate up to 1 million meals through Feeding America for each hashtag share. The initiative includes food drives at Luke Bryan's Farm Tour 2025 locations, with stops in Wisconsin, Illinois, and Michigan.

Recent research reveals concerning trends: 90% of Americans have modified shopping habits due to rising food prices, with rural families experiencing a 12-point decline in food quality compared to urban areas. To date, Bayer has provided over 10 million meals through the campaign and helped 3.4 million mothers and babies through their partnership with Vitamin Angels.

Bayer (OTC:BAYRY) announced that the FDA has accepted its New Drug Application (NDA) for gadoquatrane, a novel low-dose contrast agent for magnetic resonance imaging (MRI). The contrast agent is designed for imaging the central nervous system and other body regions in both adults and pediatric patients, including neonates.

The submitted dose of 0.04 mmol gadolinium per kilogram body weight represents a 60% reduction in gadolinium compared to current macrocyclic gadolinium-based contrast agents (GBCAs). The submission is supported by positive data from the Phase III QUANTI studies, and similar applications are under review in Japan, the European Union, and other countries.

Monsanto (OTC:BAYRY) has announced agreements in principle to resolve PCB-related litigation cases involving over 200 plaintiffs from the Sky Valley Education Center in Washington state. The settlement excludes nine prior adverse verdicts (involving 49 plaintiffs) that remain under appeal.

The settlement costs are covered by the PCB litigation provision taken in Q2 2025. The company is pursuing a strategy to contain litigation risks by the end of 2026 and has filed a complaint in Missouri to enforce indemnity contracts signed in 1972 by former electrical manufacturing customers.

Bayer (OTC:BAYRY) has announced the U.S. launch of Aspirina, its leading pain relief product in Mexico, targeting the growing Hispanic market. The strategic expansion aims to serve the Hispanic population, which currently represents 19% of the U.S. population and is projected to reach 28% by 2060.

Aspirina holds impressive market metrics in Mexico, including a 99% awareness rate and 67% regular consumer usage. The product will be available at select Walmart and Walgreens locations, leveraging Bayer's 125-year legacy in aspirin manufacturing and the strong cultural connection among Hispanic consumers, with 70% maintaining strong ties to their country of origin.

PPG (NYSE: PPG) reported record net sales of approximately $17.7 billion for 2022, marking a 5% increase from 2021, fueled by an 8% rise in organic sales due to higher prices. The company announced its 51st consecutive annual dividend hike, continuing a 123-year streak of uninterrupted payments. Key environmental achievements included a 13% reduction in greenhouse gas emissions and an investment of $16.2 million in nonprofit support, particularly in STEM education. CEO Tim Knavish expressed optimism for future growth as the economic environment improves, emphasizing cash generation and margin management. Shareholder actions included the re-election of directors and approval of executive compensation practices.

The global market for Agricultural Biotechnology is projected to grow from US$43.3 Billion in 2022 to US$88.9 Billion by 2030, reflecting a CAGR of 9.4%. The U.S. market is estimated at US$12.7 Billion, while China is expected to reach US$15.2 Billion by the same period, growing at an 8.7% CAGR. Notably, the Molecular Diagnostics segment is projected to achieve a 10.8% CAGR with an expected value of US$35.6 Billion. The report highlights significant growth in Tissue Culture at 10.1% CAGR and features key competitors including Bayer CropScience, BASF, and Syngenta. Special coverage for 2023 includes insights on the impacts of global inflation, the Russia-Ukraine conflict, and supply chain disruptions.

GreenLab, Inc. announces the appointment of Ryan Schon as the new Chief Operating Officer effective April 6, 2023. Schon will spearhead the launch of the company’s innovative GreenLab Vector Technology (GVT) platform, aimed at revolutionizing protein production in biomanufacturing.

Schon, a veteran with 25 years of experience in the seed industry, including key positions at Monsanto and Corteva, brings valuable expertise in strategy and management. His leadership is expected to enhance GreenLab's capacity to produce novel proteins while addressing crucial scalability and regulatory challenges.

The company currently has three transformative enzymes in production and is focused on commercializing the sweet recombinant protein brazzein. GreenLab aims to partner with various industries to optimize sustainable protein manufacturing.

The global Phosphoric Acid (Pharmaceutical Grade) market reached approximately 2,000,000 tonnes in 2021, with a projected growth rate of 5.16% CAGR until 2030, potentially reaching 3,000,000 tonnes. The primary driver is the Oral Care industry, utilizing phosphoric acid in dental bonding. The market is dominated by the Asia Pacific region, accounting for 45% of consumption, with China and Taiwan as key producers. The report segments the market by end-use, sales channel, and region, highlighting the significant role of phosphoric acid in dentistry and medication.